video thumbnail

Renin Angiotensin Aldosterone System (RAAS) (PM 13)

Duration: 1:02:05

Published On May 22, 2025

Write A New Comment

2 Comments

...

bobchanel@*.com

Jun 10 2026, 1:20 am

HI Dr Bean. Thank you for the awesome video. It's so densely packed with information that I'll probably come back to this several times to review it before moving on.

...

kakavand@*.com

May 25 2025, 5:47 pm

Excellent explanation.

...

mobeen@*.com

May 25 2025, 2:10 am

Thank you.

To understand how ACE inhibitors and ARBs work, we must first ground ourselves in the fundamental mechanisms of the Renin-Angiotensin-Aldosterone System (RAAS). In this lecture, we’ll focus entirely on how this hormonal system regulates blood pressure, fluid balance, and vascular resistance. We’ll explore the physiological triggers for its activation, the sequence of molecular events, and how chronic activation contributes to disease. Once we’ve established these foundational concepts, we’ll be well-positioned to discuss the pharmacology of drugs that target RAAS in the next session.

Learning Objectives:

  • Describe the physiological role of the RAAS pathway in maintaining circulatory homeostasis. 
  • Identify the key stimuli for RAAS activation (e.g., hypotension, hypovolemia, sympathetic input). 
  • Outline the sequence of events in the RAAS cascade—from renin secretion to aldosterone action. 
  • Explain the effects of angiotensin II on vascular smooth muscle, the adrenal cortex, and CNS regulation of thirst and ADH. 
  • Discuss early pathological consequences of sustained RAAS activation, such as vasoconstriction and sodium retention.
  • Differentiate between short-term adaptive roles of RAAS and long-term maladaptive consequences, preparing for next lecture’s focus on pharmacological modulation..

 

  • Describe the physiological role of the RAAS pathway in maintaining circulatory homeostasis. 
  • Identify the key stimuli for RAAS activation (e.g., hypotension, hypovolemia, sympathetic input). 
  • Outline the sequence of events in the RAAS cascade—from renin secretion to aldosterone action. 
  • Explain the effects of angiotensin II on vascular smooth muscle, the adrenal cortex, and CNS regulation of thirst and ADH. 
  • Discuss early pathological consequences of sustained RAAS activation, such as vasoconstriction and sodium retention.
  • Differentiate between short-term adaptive roles of RAAS and long-term maladaptive consequences, preparing for next lecture’s focus on pharmacological modulation..

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Faculty

In addition to the presenter, following authors may have helped with the content writing, review, or approval:

CME, CE, CEU and Other Credit Types:

ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Information

In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for Continuing Medical Education), we are committed to upholding principles of balance, independence, objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing Education (CE) activities. These policies include the careful management and mitigation of any relevant financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined that these relationships are not deemed inappropriate in the context of their respective presentations. Additionally, they are found to be consistent with the educational objectives and the integrity of the activity.

Faculty Disclosures
Author declares no conflict of interest.

Please login to access this content.

Don't have an account?

See Plans

Instructors

Pharma Mastery

Related Videos